<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="9" family="Arial,Italic" color="#000000"/>
	<fontspec id="font1" size="9" family="Arial" color="#000000"/>
	<fontspec id="font2" size="9" family="Arial,Bold" color="#000000"/>
	<fontspec id="font3" size="7" family="Arial,Italic" color="#000000"/>
	<fontspec id="font4" size="10" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font5" size="10" family="Symbol" color="#000000"/>
	<fontspec id="font6" size="10" family="Giovanni-BookItalic,Italic" color="#000000"/>
	<fontspec id="font7" size="9" family="GillSans,BoldItalic" color="#000000"/>
	<fontspec id="font8" size="10" family="Symbol" color="#ffffff"/>
	<fontspec id="font9" size="10" family="GillSans" color="#ffffff"/>
	<fontspec id="font10" size="10" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font11" size="10" family="GillSans" color="#000000"/>
	<fontspec id="font12" size="10" family="GillSans,Italic" color="#000000"/>
<text top="41" left="55" width="137" height="10" font="font0" id="p1_t1" reading_order_no="0" segment_no="0" tag_type="title"><i>Cell Communication and Signaling</i></text>
<text top="41" left="192" width="28" height="10" font="font1" id="p1_t2" reading_order_no="1" segment_no="0" tag_type="title"> 2005, </text>
<text top="41" left="220" width="5" height="10" font="font2" id="p1_t3" reading_order_no="2" segment_no="0" tag_type="title"><b>3</b></text>
<text top="41" left="225" width="12" height="10" font="font1" id="p1_t4" reading_order_no="3" segment_no="0" tag_type="title">:10</text>
<text top="41" left="383" width="171" height="10" font="font1" id="p1_t5" reading_order_no="4" segment_no="1" tag_type="text">http://www.biosignaling.com/content/3/1/10</text>
<text top="756" left="503" width="51" height="10" font="font1" id="p1_t6" reading_order_no="60" segment_no="7" tag_type="text">Page 6 of 10</text>
<text top="769" left="432" width="122" height="8" font="font3" id="p1_t7" reading_order_no="61" segment_no="8" tag_type="text"><i>(page number not for citation purposes)</i></text>
<text top="639" left="55" width="11" height="9" font="font4" id="p1_t8" reading_order_no="34" segment_no="4" tag_type="text">of </text>
<text top="637" left="67" width="5" height="13" font="font5" id="p1_t9" reading_order_no="35" segment_no="4" tag_type="text">β</text>
<text top="639" left="72" width="224" height="9" font="font4" id="p1_t10" reading_order_no="36" segment_no="4" tag_type="text">-AR mediated iNOS production after H-89 (1.8 ± 0.3</text>
<text top="651" left="55" width="69" height="9" font="font4" id="p1_t11" reading_order_no="37" segment_no="4" tag_type="text">fold over basal; </text>
<text top="651" left="124" width="8" height="9" font="font6" id="p1_t12" reading_order_no="38" segment_no="4" tag_type="text"><i>n </i></text>
<text top="651" left="133" width="163" height="9" font="font4" id="p1_t13" reading_order_no="39" segment_no="4" tag_type="text">= 5) or Rp-cAMPS pretreatment (2.2 ±</text>
<text top="662" left="55" width="84" height="9" font="font4" id="p1_t14" reading_order_no="40" segment_no="4" tag_type="text">0.6 fold over basal; </text>
<text top="662" left="139" width="8" height="9" font="font6" id="p1_t15" reading_order_no="41" segment_no="4" tag_type="text"><i>n </i></text>
<text top="662" left="147" width="149" height="9" font="font4" id="p1_t16" reading_order_no="42" segment_no="4" tag_type="text">= 3) were not significantly different</text>
<text top="674" left="55" width="241" height="9" font="font4" id="p1_t17" reading_order_no="43" segment_no="4" tag_type="text">from levels seen in the absence of PKA inhibitors (2.0 ±</text>
<text top="686" left="55" width="83" height="9" font="font4" id="p1_t18" reading_order_no="44" segment_no="4" tag_type="text">0.7 fold over basal; </text>
<text top="686" left="138" width="8" height="9" font="font6" id="p1_t19" reading_order_no="45" segment_no="4" tag_type="text"><i>n </i></text>
<text top="686" left="146" width="150" height="9" font="font4" id="p1_t20" reading_order_no="46" segment_no="4" tag_type="text">= 3). These results provide evidence</text>
<text top="698" left="55" width="241" height="9" font="font4" id="p1_t21" reading_order_no="47" segment_no="4" tag_type="text">for selective production of inflammatory mediators in</text>
<text top="709" left="55" width="158" height="9" font="font4" id="p1_t22" reading_order_no="48" segment_no="4" tag_type="text">UROtsa cells through activation of </text>
<text top="707" left="213" width="5" height="13" font="font5" id="p1_t23" reading_order_no="49" segment_no="4" tag_type="text">β</text>
<text top="709" left="218" width="78" height="9" font="font4" id="p1_t24" reading_order_no="50" segment_no="4" tag_type="text">-ARs that is inde-</text>
<text top="721" left="55" width="69" height="9" font="font4" id="p1_t25" reading_order_no="51" segment_no="4" tag_type="text">pendent of PKA.</text>
<text top="639" left="313" width="219" height="9" font="font7" id="p1_t26" reading_order_no="52" segment_no="5" tag_type="title"><i><b>PKA-Dependent Phosphorylation of the Cyclic AMP-</b></i></text>
<text top="651" left="313" width="150" height="9" font="font7" id="p1_t27" reading_order_no="53" segment_no="5" tag_type="title"><i><b>Responsive Element Binding Protein</b></i></text>
<text top="662" left="313" width="241" height="9" font="font4" id="p1_t28" reading_order_no="54" segment_no="6" tag_type="text">Since our results reveal no changes in the amount of ERK</text>
<text top="674" left="313" width="241" height="9" font="font4" id="p1_t29" reading_order_no="55" segment_no="6" tag_type="text">phosphorylation or induction of COX-2 and iNOS after</text>
<text top="686" left="313" width="241" height="9" font="font4" id="p1_t30" reading_order_no="56" segment_no="6" tag_type="text">pretreatment with selective concentrations of H-89 or Rp-</text>
<text top="698" left="313" width="241" height="9" font="font4" id="p1_t31" reading_order_no="57" segment_no="6" tag_type="text">cAMPS, it was necessary to confirm that these PKA inhib-</text>
<text top="709" left="313" width="241" height="9" font="font4" id="p1_t32" reading_order_no="58" segment_no="6" tag_type="text">itors were being used effectively in our system. Therefore,</text>
<text top="721" left="313" width="241" height="9" font="font4" id="p1_t33" reading_order_no="59" segment_no="6" tag_type="text">we examined the isoproterenol mediated phosphoryla-</text>
<text top="446" left="55" width="5" height="13" font="font8" id="p1_t34" reading_order_no="5" segment_no="2" tag_type="title">β</text>
<text top="449" left="60" width="414" height="9" font="font9" id="p1_t35" reading_order_no="7" segment_no="2" tag_type="title">-AR stimulated expression of pro-inflammatory mediators occurs through PKA-independent mechanisms</text>
<text top="449" left="55" width="37" height="9" font="font10" id="p1_t36" reading_order_no="6" segment_no="2" tag_type="title"><b>Figure 6</b></text>
<text top="457" left="55" width="5" height="13" font="font5" id="p1_t37" reading_order_no="8" segment_no="3" tag_type="text">β</text>
<text top="459" left="60" width="479" height="9" font="font10" id="p1_t38" reading_order_no="9" segment_no="3" tag_type="text"><b>-AR stimulated expression of pro-inflammatory mediators occurs through PKA-independent mechanisms</b></text>
<text top="459" left="539" width="5" height="9" font="font11" id="p1_t39" reading_order_no="10" segment_no="3" tag_type="text">. </text>
<text top="470" left="55" width="209" height="9" font="font11" id="p1_t40" reading_order_no="11" segment_no="3" tag_type="text">After a 30 min pre-incubation with 100 nM of H-89 (</text>
<text top="470" left="264" width="28" height="9" font="font12" id="p1_t41" reading_order_no="12" segment_no="3" tag_type="text"><i>panel A</i></text>
<text top="470" left="292" width="30" height="9" font="font11" id="p1_t42" reading_order_no="13" segment_no="3" tag_type="text">) or 10 </text>
<text top="467" left="322" width="6" height="13" font="font5" id="p1_t43" reading_order_no="14" segment_no="3" tag_type="text">µ</text>
<text top="470" left="327" width="68" height="9" font="font11" id="p1_t44" reading_order_no="15" segment_no="3" tag_type="text">M of Rp-cAMPS (</text>
<text top="470" left="396" width="28" height="9" font="font12" id="p1_t45" reading_order_no="16" segment_no="3" tag_type="text"><i>panel B</i></text>
<text top="470" left="423" width="128" height="9" font="font11" id="p1_t46" reading_order_no="17" segment_no="3" tag_type="text">), UROtsa cells were stimulated </text>
<text top="481" left="55" width="492" height="9" font="font11" id="p1_t47" reading_order_no="18" segment_no="3" tag_type="text">with 100 nM isoproterenol in serum-free DMEM for the indicated times and immunoblotted with anti-COX-2 or anti-iNOS </text>
<text top="492" left="55" width="91" height="9" font="font11" id="p1_t48" reading_order_no="19" segment_no="3" tag_type="text">antibody to determine </text>
<text top="489" left="146" width="5" height="13" font="font5" id="p1_t49" reading_order_no="20" segment_no="3" tag_type="text">β</text>
<text top="492" left="152" width="394" height="9" font="font11" id="p1_t50" reading_order_no="21" segment_no="3" tag_type="text">-AR mediated changes in protein expression. Peak UROtsa cell expression of the pro-inflammatory </text>
<text top="502" left="55" width="498" height="9" font="font11" id="p1_t51" reading_order_no="22" segment_no="3" tag_type="text">mediators COX-2 and iNOS was observed 2 hrs after addition of isoproterenol even after pre-incubation with selective PKA </text>
<text top="513" left="55" width="43" height="9" font="font11" id="p1_t52" reading_order_no="23" segment_no="3" tag_type="text">inhibitors (</text>
<text top="513" left="98" width="57" height="9" font="font12" id="p1_t53" reading_order_no="24" segment_no="3" tag_type="text"><i>panels C and D</i></text>
<text top="513" left="155" width="398" height="9" font="font11" id="p1_t54" reading_order_no="25" segment_no="3" tag_type="text">). Levels of COX-2 generated in the presence of H-89 or Rp-cAMPS were significantly increased 3.0 </text>
<text top="524" left="55" width="499" height="9" font="font11" id="p1_t55" reading_order_no="26" segment_no="3" tag_type="text">± 0.4 and 2.5 ± 0.7 fold over basal, respectively. However these isoproterenol induced levels of COX-2 were not significantly </text>
<text top="535" left="55" width="499" height="9" font="font11" id="p1_t56" reading_order_no="27" segment_no="3" tag_type="text">different from cells pretreated in the absence of inhibitor (1.9 ± 0.5 fold over basal). Likewise, levels (fold over basal) of iNOS </text>
<text top="545" left="55" width="499" height="9" font="font11" id="p1_t57" reading_order_no="28" segment_no="3" tag_type="text">production generated by isoproterenol after H-89 (1.8 ± 0.3) or Rp-cAMPS pretreatment (2.2 ± 0.6) were significantly greater </text>
<text top="556" left="55" width="487" height="9" font="font11" id="p1_t58" reading_order_no="29" segment_no="3" tag_type="text">than basal. However these responses were not significantly different from levels observed for isoproterenol induced iNOS </text>
<text top="567" left="55" width="497" height="9" font="font11" id="p1_t59" reading_order_no="30" segment_no="3" tag_type="text">production in the absence of PKA inhibitors (2.0 ± 0.7). Values are presented as the mean ± S.E. and the autoradiographs are </text>
<text top="578" left="55" width="124" height="9" font="font11" id="p1_t60" reading_order_no="31" segment_no="3" tag_type="text">representative immunoblots of </text>
<text top="578" left="180" width="7" height="9" font="font12" id="p1_t61" reading_order_no="32" segment_no="3" tag_type="text"><i>n </i></text>
<text top="578" left="187" width="173" height="9" font="font11" id="p1_t62" reading_order_no="33" segment_no="3" tag_type="text">= 3–5 independent UROtsa cell treatments.</text>
</page>
</pdf2xml>
